Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
Zinzani PL, Tani M, Pulsoni A, De Renzo A, Stefoni V, Broccoli A, Montini GC, Fina M, Pellegrini C, Gandolfi L, Cavalieri E, Torelli F, Scopinaro F, Argnani L, Quirini F, Derenzini E, Rossi M, Pileri S, Fanti S, Baccarani M. Zinzani PL, et al. Among authors: cavalieri e. Ann Oncol. 2012 Feb;23(2):415-20. doi: 10.1093/annonc/mdr145. Epub 2011 May 2. Ann Oncol. 2012. PMID: 21536660 Free article. Clinical Trial.
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
Cavalieri E, Matturro A, Annechini G, De Angelis F, Frattarelli N, Gentilini F, Grapulin L, Sacco M, Torelli F, Vignetti M, Mandelli F, Foà R, Pulsoni A. Cavalieri E, et al. Leuk Lymphoma. 2009 Nov;50(11):1803-8. doi: 10.3109/10428190903254383. Leuk Lymphoma. 2009. PMID: 19860621 Clinical Trial.
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study.
Levis A, Anselmo AP, Ambrosetti A, Adamo F, Bertini M, Cavalieri E, Gavarotti P, Genua A, Liberati M, Pavone V, Pietrasanta D, Ricetti MM, Scalabrini DR, Salvi F, Vitolo U, Angelucci E, Boccadoro M, Gallo E, Mandelli F; Intergruppo Italiano Linfomi (IIL). Levis A, et al. Among authors: cavalieri e. Ann Oncol. 2004 Jan;15(1):123-8. doi: 10.1093/annonc/mdh012. Ann Oncol. 2004. PMID: 14679131 Free article.
Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
Pulsoni A, Starza ID, Frattarelli N, Ghia E, Carlotti E, Cavalieri E, Matturro A, Tempera S, Rambaldi A, Foà R. Pulsoni A, et al. Among authors: cavalieri e. Br J Haematol. 2007 May;137(3):216-20. doi: 10.1111/j.1365-2141.2007.06545.x. Br J Haematol. 2007. PMID: 17408460 Free article.
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.
Franklin J, Pluetschow A, Paus M, Specht L, Anselmo AP, Aviles A, Biti G, Bogatyreva T, Bonadonna G, Brillant C, Cavalieri E, Diehl V, Eghbali H, Fermé C, Henry-Amar M, Hoppe R, Howard S, Meyer R, Niedzwiecki D, Pavlovsky S, Radford J, Raemaekers J, Ryder D, Schiller P, Shakhtarina S, Valagussa P, Wilimas J, Yahalom J. Franklin J, et al. Among authors: cavalieri e. Ann Oncol. 2006 Dec;17(12):1749-60. doi: 10.1093/annonc/mdl302. Epub 2006 Sep 19. Ann Oncol. 2006. PMID: 16984979 Free article.
252 results